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To investigate the molecular mechanisms involved in paramyxovirus-induced cell fusion, the function and structure of a
peptide with a 20-amino-acid sequence from the leucine zipper region (heptad repeat region 2) of the Newcastle disease
virus fusion protein (F) were characterized. A peptide with the sequence ALDKLEESNSKLDKVNVKLT (amino acids 478–497
of the F protein) was found to inhibit syncytia formation after virus infection and after transfection of Cos cells with the HN
(hemagglutinin-neuraminidase) and F protein cDNAs. Using an F protein gene that requires addition of exogenous trypsin
for cleavage, it was shown that the peptide exerted its inhibitory effect prior to cleavage. The three-dimensional conformation
of the peptide in aqueous solution was determined through the use of NMR and molecular modeling. Results showed that
the peptide formed a helix with properties between an a-helix and a 310-helix and that leucine residues aligned along one
face of the helix. Side chain salt bridges and hydrogen bonds likely contributed to the stability of the peptide secondary
structure. Analysis of the aqueous solution conformation of the peptide suggested mechanisms for specificity of interaction
with the intact F protein. q 1997 Academic Press
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INTRODUCTION called the fusion sequence or fusion peptide, thought to
insert into the bilayer of the target membrane (Hernandez
Fusion between viral and cellular membranes is re-
et al., 1996; White, 1990). In many cases, this sequence
quired for enveloped virus infection. For most enveloped
is adjacent to a cleavage site in a precursor molecule
viruses, exemplified by influenza virus, fusion occurs in (Hernandez et al., 1996). Thus cleavage, which is usually
the endosome after a viral fusion protein has been acti- necessary for fusion, positions this sequence at an
vated at the low pH in that organelle (Hernandez et al., amino terminus. As initially pointed out by Chambers et
1996; White, 1992). However, some viruses, notably para- al. (1990), fusion proteins often have heptad repeat (HR)
myxoviruses (Lamb, 1993) and some retroviruses (Her- regions adjacent to the fusion peptide. It is now recog-
nandez et al., 1996), fuse with cellular plasma mem- nized that many fusion proteins have at least two heptad
branes at neutral pH. Cells infected with these viruses repeats, one of which has a leucine-isoleucine zipper
can also fuse with adjacent cells to form syncytia. Activa- motif (Buckland and Wild, 1989; Wild et al., 1994a,b). The
tion of fusion proteins which function at neutral pH is roles of these heptad repeat regions are ill defined.
poorly understood but may be related, at least in part, to Membrane fusion mediated by paramyxoviruses, such
virus attachment to its receptor (Lamb, 1993; Sergel et as the Newcastle disease virus (NDV), requires two gly-
al., 1993). coproteins, the attachment protein (hemagglutinin-neur-
All enveloped viruses have one or more glycoproteins aminidase or HN) and the fusion protein (F) (Lamb, 1993).
that have been directly implicated in the fusion event The F protein is thought to be directly involved in the
(Hernandez et al., 1996). Most of these fusion proteins fusion event, while the HN protein plays an undefined
have a recognizable hydrophobic or apolar sequence, role in membrane fusion (Lamb, 1993). The F protein is
synthesized as a precursor (F0) which must be cleaved
to produce disulfide-linked F1 and F2 required for fusion1 To whom NMR and molecular modeling correspondence should
(Scheid and Choppin, 1974, 1978; White, 1990). The fu-be addressed at Department of Chemistry, Colgate University, 13 Oak
Drive, Hamilton, NY 13346. Fax: (315) 824-7935. E-mail: jkyoung@cent- sion peptide is located at the new amino terminus of F1
er.colgate.edu. generated by cleavage. The F1 protein has two heptad2 To whom biological data correspondence and reprint requests repeats; one is adjacent to the fusion peptide (HR1) and
should be addressed at Department of Molecular Genetics and Micro-
the second (HR2) is adjacent to the transmembrane do-biology, University of Massachusetts, 55 Lake Avenue North, Worces-
main (Buckland et al., 1992; Buckland and Wild, 1989;ter, MA 01655. Fax: (508) 856-1506. E-mail: trudy.morrison@banyan.
ummed.edu. Chambers et al., 1990). The HR2 sequence contains a
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zipper motif, with L or I every seven residues (Buckland Cells, vectors, and viruses
and Wild, 1989). Mutational analysis has shown that both
Cos-7 cells, obtained from the American Type Culture
HR1 and HR2 are involved in the fusion activity of the F
Collection, were maintained in Dulbecco’s modified Ea-
protein (Buckland et al., 1992; Reitter et al., 1995; Sergel-
gle’s medium (DMEM) supplemented with nonessential
Germano et al., 1994).
amino acids, vitamins, penicillin/streptomycin, and 10%
Recently it has been reported that synthetic peptides
fetal calf serum. NDV, strains AV and B1, were grown
with sequences from heptad repeat regions of HIV gp41
in chicken embryos and purified using standard proto-
(Wild et al., 1992, 1994b) and paramyxovirus F1 proteins cols. Strain AV is a virulent NDV which has a furin
can inhibit fusion (Lambert et al., 1996; Rapaport et al., recognition site at the F protein cleavage site, while
1995; Yao and Compans, 1996). Initially reported by Wild strain B1 is avirulent and requires addition of exoge-
et al. (1992), it was found that peptides with the se- nous trypsin for F0 protein cleavage (Glickman et al.,quences of either heptad repeat region in the HIV gp41 1988; Toyoda et al., 1987). NDV HN and F genes (de-
protein inhibited fusion (Wild et al., 1992, 1994b). Pep- rived from strain AV) were expressed in Cos cells using
tides corresponding to the HR2 region of the F1 protein pSVL obtained from Pharmacia as previously described
were the most potent inhibitors of paramyxovirus fusion (Sergel et al., 1993). Viral genes were inserted into SacI
(Lambert et al., 1996). It has been suggested that the and XbaI cut plasmid DNA.
inhibitory activity of these peptides is due to their ability
to mimic functional domains of the corresponding fusion Trypsin digestion
protein, thereby interfering with the normal function of
Cells were washed three times in OptiMem (BRL/the protein (Lambert et al., 1996; Rapaport et al., 1995;
Gibco), incubated in OptiMem containing 5 mg/ml of ace-Yao and Compans, 1996). However, the precise mecha-
tylated trypsin at room temperature for 10 min, washed innisms involved are not clear. Furthermore, the three-di-
OptiMem containing 20 mg/ml soybean trypsin inhibitor,mensional conformation of these peptides has not been
washed in OptiMem, and then incubated in DMEM.extensively analyzed. While the HR2 regions of para-
myxovirus fusion proteins have been predicted to be a-
Transfectionshelical (Lamb, 1993), Lambert et al. (1996) reported that
peptides with these sequences from three different para- Transfections using lipofectin were done essentially
myxoviruses exhibit little helicity by CD analysis in water. as recommended by the manufacturer (BRL/Gibco). Cos
In order to investigate the molecular mechanisms in- cells were plated at 2 1 105 per 35-mm plate and trans-
volved in paramyxovirus fusion, we have begun to char- fected 18 h later. For each 35-mm plate, a mix of 1.5 mg
acterize the functional and structural properties of a pep- HN DNA and 1.5 mg F DNA in 0.1 ml OptiMem and 10
tide with a 20-amino-acid sequence from the HR2 region ml of lipofectin in 0.1 ml of OptiMem was incubated at
room temperature for 45 min and then diluted with 0.7(zipper motif) of the NDV (strain AV) F protein. We report
ml OptiMem and added to a plate previously washedhere that a synthetic peptide derived from the carboxyl-
with OptiMem. Cells were incubated with the lipofectin–terminal region (aa 478 –497  ALDKLEESNSKLDKV-
DNA for 5.5 h and then 2 ml of Cos cell medium wasNVKLT) of HR2 inhibited fusion, consistent with reports
added.in other paramyxovirus systems (Lambert et al., 1996;
Rapaport et al., 1995; Yao and Compans, 1996). The
Fusion assaysthree-dimensional conformation of this peptide has also
been determined through the use of nuclear magnetic At 48 h posttransfection, the number of nuclei in 40
resonance spectroscopy (NMR) and molecular modeling fusion areas was counted to determine the average size
in order to begin to understand the structural basis for at each time point as previously described (Sergel et al.,
inhibition of fusion. 1993). Values obtained after transfection of the vector
alone were subtracted.
MATERIALS AND METHODS NMR sample preparation and experiments
NMR samples were prepared by dissolving 2 mg ofPeptide
the synthetic peptide in 500 ml of 90% 1H2O/10%
2H2O to
Peptide WTF20, which corresponds to a 20-aa seg- a final concentration of 1.60 mM (90% purity correction).
ment (aa 478–497) of HR2 of the NDV F protein, was The solution was buffered to pH 4.00 using 30 mM deu-
obtained from Tufts University School of Medicine Pep- terated sodium acetate. Sodium 2,2-dimethyl-2-silapen-
tide Core Facility (136 Harrison Avenue, Boston, MA.). tane-5-sulfonate was used as an internal chemical shift
The peptide was purified by the Tufts facility to 98% using reference.
HPLC. This peptide was used for both biological and All NMR experiments were conducted at the Missis-
sippi State Magnetic Resonance Facility in the ChemistryNMR studies without further purification.
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Department of Mississippi State University on a Bruker of the molecule (Clore et al., 1985; Young et al., 1994;
Young and Hicks, 1994). Structures were generated forAMX 600-MHz NMR spectrometer with the use of the 1H
channel of a triple resonance probe (1H/13C/15N). Spectra WTF20 with the NMR-derived interproton distance re-
straints and hydrogen bond data using simulated anneal-were processed and interpreted at the University of Mas-
sachusetts Medical Center using Felix 95.0 from Molecu- ing calculations involving 16 separate phases. These cal-
culations began with an arbitrary or linear extended con-lar Simulations Inc. on a Silicon Graphics Impact 10000:
Indigo2. formation to prevent any initial bias in the starting
structure toward a particular secondary structural fea-The 1D 1H spectra were acquired every 57 over a tem-
perature range of 20 to 457 at a spectral width of 7812.5 ture. The first phase involved randomization of all atomic
coordinates by 10 A˚ followed by 100 iterations ofHz, with 32K data points for a digital resolution of 0.2211
Hz per point, yielding a total acquisition time of 2.261 s. steepest minimization using a quadratic potential and
very low force fields for each term of the pseudo-energyA total of 32 scans were acquired and then processed
to 64K points with an exponential multiplication of 1 Hz function. Phase 2 involved additional minimization with
1500 iterations of conjugate minimization. During theseline broadening. The 1H2O signal was suppressed using
watergate with a sine gradient. minimization steps (1 and 2 or preparation stage) the
covalent force fields were reduced to 0.02% of their fullSix phase-sensitive watergate-TOCSY (Eich et al.,
1982; Hicks and Young, 1994) experiments were ac- value, and experimental (interproton distances and hy-
drogen bonds), nonbond, and chiral force fields werequired every 57 over a temperature range of 20 to 457
with a spin-lock mixing pulse of 80 ms, using a MLEV- reduced to 0.1% of their full value. Phases 3 through 5
involved simulated annealing with restrained dynamics17 mixing sequence with a 2.5-ms trim pulse at the begin-
ning and end of the MLEV sequence (Bax and Davis, for 30 ps with scaling of the force fields. Molecular dy-
namics (phase 3 or folding stage) was applied using1985). The spectral width in both domains was set to
7812.5 Hz, yielding a digital resolution of 15.26 Hz per weak force fields to allow the potential energy of the
system to equal the kinetic energy at 1000K. The lowpoint in f1 and 3.81 Hz per point in f2 and a total acquisi-
tion time of 0.1311 s. At the beginning of each experi- values of the force fields allow atoms and bonds to pass
through each other (Clore et al., 1985). In this foldingment, 32 dummy scans were collected to allow the sys-
tem to reach thermal equilibrium. A total of 2K time-do- stage the experimental force fields were scaled up to
their full value, covalent and chiral force fields to 15% ofmain data points for 512 t1 values of 32 scans each was
acquired and then zero filled to 4K 1 4K, followed by their full value, and nonbond force fields to 0.1% of their
full value. Next, the regulation stage (phase 4) scaled upprocessing with a 907 shifted sine function in both dimen-
sions. After investigation of each TOCSY spectrum, it was the covalent force fields to their full value and nonbond
to 15% of their full value, so the coordinates of all thedetermined that the experiment acquired at 257 provided
the best amide peak to peak resolution. atoms were more tightly held. Phase 5 restrained the
molecule significantly by scaling chiral force fields toThe phase-sensitive watergate-ROESY (Rotating Over-
hauser Enhancement Spectroscopy; Bull, 1988) experi- their full value, nonbond to 25% of their full value, and
experimental to two times their full value. Phases 6ment was acquired with a mixing pulse of 300 ms at 257.
The spectral width in both domains was set to 7812.5 through 10 involved cooling of the molecule from 1000
to 300K over 10 ps (2 ps for each phase) with nonbondHz, yielding a digital resolution of 7.62 Hz per point in f1
and 3.81 Hz per point in f2 and a total acquisition time force fields scaled to their full value. The next two phases
(11 and 12) involved 100 iterations of steepest and 1500of 0.1311 s. At the beginning of each experiment, 32
dummy scans were collected to allow the system to iterations of conjugate minimization while scaling non-
bond force fields to their full value. Phases 13 and 14reach thermal equilibrium. A total of 2K time-domain data
points for 512 t1 values of 64 scans each was acquired involved 100 iterations of steepest and 1500 iterations of
conjugate minimization while the experimental forceand then zero filled to 4K 1 4K, followed by processing
with a 907 shifted sine function in both dimensions. fields were scaled back to their full value. The final
phases (14 and 15) involved 100 iterations of steepest
and 1500 iterations of conjugate minimization with a Len-Molecular modeling
nard–Jones potential (Young et al., 1997).
The final structures were analyzed by the superimposi-The molecular modeling (simulated annealing) calcu-
lations conducted during this investigation were per- tion of the backbone atoms to determine if the structures
converged to a single family of conformations or definedformed using the BioSym software (InsightII, NMRchitect
and Discover) from Molecular Simulations Inc. on a Sili- multiple families of conformations. The dihedral angles
were then averaged over the number of structures in acon Graphics Impact 10000: Indigo2 at the University of
Massachusetts Medical Center. Simulated annealing family of conformations to determine what, if any, sec-
ondary structural features were defined by the experi-calculations involved the search of all conformational
space to find the global minimum energy conformation mental data (Clore et al., 1985).
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FIG. 1. Location of the sequence of the synthetic peptide WTF20. (A) Diagram of the fusion protein of NDV with the approximate location in the
linear sequence of structurally significant domains: HR1, heptad repeat 1; HR2, heptad repeat 2, which contains a zipper motif; S-S, the likely
disulfide linkage between F2 and F1 (Iwata et al., 1994). (B) The sequence of the HR2 region of the F protein of NDV with the zipper residues labeled
L1 through I6. (C) Linear amino acid sequence of the WTF20 peptide. (D) Distribution of the amino acids of WTF20 in the helical wheel representation.
Literature describing zippers places the leucines or isoleucines that make up a zipper in the ‘‘d’’ position of the helical wheel representation while
the ‘‘a’’ position usually contains other hydrophobic residues as well as asparagines (O’Shea et al., 1992). If this same representation is used for
the zipper region of different paramyxoviruses, many charged residues will occur in the ‘‘a’’ position. Therefore, we have shown the leucines (L5,
L12, and L19) that make up the WTF20 zipper in the ‘‘a’’ position.
RESULTS To determine if the WTF20 peptide inhibited fusion di-
rected by the HN and F proteins and to quantitate inhibi-Synthetic peptide sequence
tion, Cos cells were transfected with HN and F cDNAsThe HR2 region of the NDV F1 protein is located just and incubated in the presence of various concentrationsto the amino-terminal side of the transmembrane domain
of peptide, and fusion was measured by the size of syncy-(Fig. 1A) (Reitter et al., 1995). Beginning at aa 467 and
tia at 48 h after transfection. Figure 2 shows that theextending to aa 502, there are six leucine or isoleucine
WTF20 peptide inhibited the formation of syncytia. Theresidues every seven residues (Fig. 1B). We have pre-
concentration required for 50% inhibition was approxi-viously reported that mutation of any two of the L3, L4,
mately 2 mM, a concentration similar to that reportedand L5 residues eliminated the fusion activity of the F
in other paramyxovirus systems (Lambert et al., 1996;protein (Reitter et al., 1995). Therefore, we chose our
Rapaport et al., 1995; Yao and Compans, 1996).synthetic peptide, WTF20 (Figs. 1C and 1D), to include
L3 and L5. We also included the leucine between L2 and Dependence of inhibition of fusion on time of addition
L3 since it was the only other leucine or isoleucine in
NDV, strain B1, was used to determine if the WTF20HR2. In addition, previous reports suggested that pep-
peptide exerted its effect before or after cleavage of thetides with sequences from the carboxyl-terminal region
F0 protein. The F0 protein of this virus lacks a furin recog-of the HR2 were more inhibitory than those from the
nition sequence and requires the addition of exogenousamino-terminal region (Lambert et al., 1996).
trypsin for cleavage (Glickman et al., 1988; Toyoda et al.,
Inhibition of fusion mediated by F and HN proteins 1987). Cells infected with strain B1 for 12 h showed no
fusion (Fig. 3A). However, if the infected cells were incu-As reported in other systems, WTF20 inhibited cell–
cell fusion after infection with NDV, strain AV (not shown). bated with trypsin for 10 min, the cells rapidly fused (Fig.
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3B). Cells infected with B1 in the presence or absence
of peptide during virus adsorption and then incubated
with peptide during the entire infection period did not
fuse (Figs. 3C and 3D). To determine when the peptide
was required for inhibition, cells infected with B1 were
treated with peptide before trypsin activation (Fig. 3E) or
after trypsin activation (Fig. 3F). Clearly significant inhibi-
tion was observed in cells incubated with peptide only
before trypsin activation (compare Figs. 3E and 3F). In-
deed, the extent of inhibition was similar to that observed
if peptide was present during the entire infection period,
both before and after trypsin treatment (compare Figs. 3D
and 3E). Surprisingly, there was little inhibition of fusion
if the peptide was added only after cleavage (Fig. 3F).
To quantitate this effect, a similar experiment was car-
ried out in cells transfected with cDNA encoding an F
protein mutant which required trypsin activation. We have
previously reported that substitution of phenylalanine
(aa117) by leucine at the amino terminus of F1 inhibited
the intracellular cleavage of the F0 protein (Morrison et
al., 1993). However, addition of exogenous trypsin re-
sulted in cleavage of F0 and subsequent fusion (Morrison
et al., 1993). Cells transfected with this mutant F as wellFIG. 2. Peptide inhibition of fusion. Cells cotransfected with HN
and F cDNAs (derived from the virulent strain of NDV and, therefore, as HN cDNA were incubated with peptide prior to trypsin
resulting in a protein that is cleaved intracellularly) as described under activation, after trypsin activation, or both. Upon addition
Materials and Methods were incubated with 0 to 50 mM WTF20 pep- of trypsin at 48 h posttransfection, syncytia developed in
tide added with complete medium after transfection. Medium with
the untreated cells (0/0) and no syncytia were seenpeptide was replaced every 12 h. Size of syncytia was determined at
when peptide was present both before and after trypsin48 h after transfection as previously described (Sergel et al., 1993).
Values obtained are shown as a percentage of those obtained without addition (///) (Fig. 4). In addition, no syncytia were ob-
peptide. served in cells incubated with peptide only prior to addi-
tion of trypsin (//0), while the peptide had little effect
FIG. 3. Effect of time of addition of peptide after NDV, strain B1, infection. Cells were infected with NDV, strain B1, at a multiplicity of infection
of 1. At 12 h postinfection, cells were incubated with 5 mg/ml trypsin as described under Materials and Methods, and incubation was continued
for 4 h. Monolayers were fixed with methanol and stained with Giemsa. (A) No trypsin added, no peptide; (B) trypsin added, no peptide; (C) peptide
(20 mM) was added prior to adsorption, after adsorption, and after trypsin treatment; (D) peptide (20 mM) was added after adsorption and after
trypsin treatment; (E) peptide (20 mM) was added after adsorption and present until trypsin digestion; (F) peptide (20 mM) was added only after
trypsin treatment.
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distinguishable from the other spin systems because of
the similarities in the pattern of cross peaks of certain
amino acids (L  V, D  N). As a first step, each set of
signals or spin systems from the fingerprint region of the
TOCSY spectrum (Fig. 5) was tentatively assigned to an
amino acid(s). For example, threonine showed cross
peaks from its amide 1H to its a, b, and g 1Hs as illus-
trated on the spectrum. However, it was not possible to
make specific assignments of like (L2, L5, L12, L19) or
similar amino acids (L, V and D, N) using the TOCSY
spectrum because of the high occurrence of these resi-
dues in this peptide. Therefore, the ROESY experiment
was used to make sequence-specific assignments
(Wu¨thrich, 1986).
The ROESY (Bull, 1988) experiment was used instead
of the traditional NOESY (States et al., 1982) experiment to
eliminate the possibility of spin diffusion (Atta-ur-Rahman,
1989; Homans, 1989). In the ROESY spectrum, the diago-
nal peaks as well as any cross peaks that occur because
of through bond coupling or spin diffusion have a positive
phase, while cross peaks that result from through space
FIG. 4. Effect of time of addition of peptide after transfection. Cells (dipole–dipole) interactions have a negative phase.
transfected with HN and F117L cDNAs as described under Materials Therefore, a negative cross peak occurs when a 1H is
and Methods were incubated with or without 20 mM WTF20 peptide
within 4–5 A˚ of another 1H (Bull, 1988). In the ROESYadded with complete medium after transfection. Medium with or without
spectrum, an amide 1H shows cross peaks to 1Hs in itspeptide was replaced every 12 h. At 48 h posttransfection, cells were
incubated with trypsin as described under Materials and Methods. own spin system and to 1Hs in the i to i-1 spin system,
Incubation was continued, with or without peptide, for 7.5 h. The sizes as seen in Fig. 6. Residue T20 provides a good starting
of syncytia were measured over time, and values obtained after trans- point to obtain sequence-specific assignments by follow-
fection with vector alone were subtracted. The data are the average
ing its amide 1H cross peaks backward throughout theof three independent experiments.///, peptide added before and after
peptide since it is the only unique amino acid in thistrypsin; 0/0, no peptide added; //0, peptide added before trypsin;
0//, peptide added after trypsin. peptide. The amide 1H of T20 showed cross peaks to its
own spin system as in the TOCSY spectrum as well as
cross peaks to one of the leucine spin systems, allowing
on syncytia formation if present only after trypsin addition for the assignment of this leucine spin system to L19 (Fig.
(0//). These results clearly showed that the WTF20 pep- 6). This procedure was followed throughout the peptide,
tide exerted its effect prior to the cleavage of the F0 providing complete 1H chemical shift assignments of
protein and the initiation of fusion, both of which likely WTF20 in aqueous solution (Table 1).
occur during incubation with trypsin.
Amide chemical shift temperature dependenceNMR assignments
(ACSTD)
Assignments of the 1H spectra of the WTF20 peptide
(Fig. 1C) in aqueous solution were accomplished using Amide 1Hs are directly affected by changes in tempera-
ture, which cause a change in the amide’s chemical shiftthe technique of sequence-specific resonance assign-
ments developed by Wu¨thrich (1986). The assignments and can be related to intramolecular hydrogen bonding
(Rose et al., 1985). An amide 1H that is involved in anwere made by the interactive interpretation of the 2D
TOCSY (Eich et al., 1982; Hicks and Young, 1994) and intramolecular hydrogen bond is shielded from the sol-
vent and therefore shows a low temperature dependenceROESY (States et al., 1982) spectra at 257. From the
TOCSY (Total Correlation Spectroscopy) spectrum a set (small change in chemical shift), while solvent accessible
amide 1Hs show a high temperature dependence (largeof resonances can be assigned to a particular spin sys-
tem (amino acid). Cross peaks in the TOCSY spectrum change in chemical shift). At higher temperatures, some
of the amide protons of WTF20 overlapped, making thearise due to through bond interactions (Davis and Bax,
1985). For example, an amide 1H magnetization will travel temperature dependence hard to determine from the 1D
spectra. Therefore, six TOCSY spectra (every 57) werethrough bond to the other 1Hs in its own spin system
until interrupted by a unprotonated position (Eich et al., acquired over a temperature range of 20 to 457 in order
to unambiguously assign the amide chemical shifts1982). This peptide contains nine spin systems (A,L,D,K,
E,S,N,V,T); however, only six of these spin systems were (Young et al., 1997). A plot of the chemical shift vs temper-
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FIG. 5. Fingerprint region of the TOCSY spectrum of WTF20. Each spin system is shown with the tentative amino acid assignments. The T spin
system is shown with its a, b, and g 1Hs labeled.
ature resulted in a linear dependence for each amide helical structure since this ROE is observed only in heli-
ces (Clore et al., 1985; Gierasch et al., 1982; Wu¨thrich,proton (Gierasch et al., 1982). The slope of this linear
dependence is the ACSTD, and the values are shown in 1986). The observation of seven daN(i,i/ 2) connectivities
suggests a 310-helix, while the observation of four daN(i,iTable 1 for WTF20. The low temperature dependence
(less than 05 ppb/7) for the amide 1Hs of K11, L12, D13, / 4) suggests an a-helix.
V15, and T20 suggests the presence of five intramolecu-
Molecular modelinglar hydrogen bonds.
One hundred structures were generated for WTF20
ROE connectivity
using the NMR-derived distance constraints and intramo-
lecular hydrogen bond data by simulated annealing cal-Wu¨thrich and co-workers have reported that the obser-
vation of a grouping of specific medium-range ROEs can culations involving 16 separate phases as described un-
der Materials and Methods. A total of 175 ROEs werebe used to determine the existence of secondary struc-
tural features such as an a-helix or a b-turn (Wu¨thrich assigned from the ROESY spectrum collected at a mixing
time of 300 ms. Of these ROEs, 79 represented intrare-et al., 1984). The ROEs, obtained from the ROESY spec-
trum, that are important to characterize the secondary sidue interactions, 56 represented i to i / 1 interactions,
and 40 represented medium range (i to i / 2, i to i /structure of WTF20 are shown in Fig. 7. These ROEs
suggest that the secondary structure of WTF20 may be 3, and i to i / 4) interactions. These interactions were
converted to interproton distances using the strong, me-helical due the occurrence of strong sequential dNN(i,i /
1), medium range dNN(i,i / 3), daN(i,i / 3), and dab(i,i / dium, and weak designations of Clore and Gronenborn
(Clore et al., 1985). This method involves visually in-3) and weak dNN(i,i / 2), daN(i,i / 2), and daN(i,i / 4) ROE
connectivities. In particular, the nine medium range dab(i,i specting the ROESY spectrum and assigning each cross-
peak intensity to an interproton distance of 1.9 to 2.7 A˚/ 3) ROEs strongly suggest that this peptide exists in a
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FIG. 6. Fingerprint region of the ROESY spectrum of WTF20. Each spin system is shown with the final amino acid assignments. The T20 spin
system is shown with its a, b, and g 1Hs labeled as well as the cross peaks to the a, b, and g of the L19 spin system.
for strong, 1.9 to 3.3 A˚ for medium, and 1.9 to 4.0 A˚ for bone atoms superimposed showing convergence to a
helical structure. The average energy of the resultingweak (see Fig. 7).
As a first step, 20 structures of WTF20 were generated structures was 290 kcal/mol. The root mean squared
deviations of the backbone atoms for the 100 structuresusing only interproton distance data to determine if a
secondary structure existed. It was evident from the re- ranged from 0.01 to 0.80 A˚.
sulting structures that a stable helix was present through-
out the peptide. The five intramolecular hydrogen bonds DISCUSSION
determined from the ACSTD study (Table 1) were as-
Peptide secondary structure
signed based on these structures. Hydrogen bonds
within a reverse turn represent an i to i / 3 interaction, To characterize the secondary structural features of the
WTF20 peptide, the individual backbone dihedral angleswhile those in a helical structure represent an i to i / 4
interaction (Creighton, 1984; Wu¨thrich et al., 1984). There- were averaged over the 100 structures obtained from mo-
lecular modeling and are given in Table 2. Dihedralfore, the five hydrogen bonds were defined from the am-
ide 1H of K11, L12, D13, V15, and T20 to the backbone angles that vary by {207 or less are considered sufficient
to compare with ideal dihedral angles of known second-carbonyl oxygen of E7, S8, N9, K11, and N16, respec-
tively. All hydrogen bonds were assigned a distance of ary structural features (Creighton, 1984). For WTF20 all
dihedral angles vary by only {10.97 or less with the ex-2.5 A˚. Another 20 structures generated using interproton
distance and hydrogen bond data converged to one fam- ception of A1 (C  051.1 { 28.0) and T20 (f  032.9
{ 81.9), consistent with the greater degree of motionily of conformations. Therefore, 100 structures were gen-
erated for final analysis using the protocols described expected at each terminus. These dihedral angles (aver-
age L2–L19, f  068.6, C  031.5) do not correspondunder Materials and Methods. Twenty randomly selected
structures of WTF20 are shown in Fig. 8A, with all back- to either an ideal right-handed a-helix (f  057, C 
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TABLE 1
1H Chemical Shift (ppm) Assignment of 1.6 mM WTF20 at pH 4.0 in Aqueous Solution as Obtained from the TOCSY and ROESY Spectra at
257 and ACSTD (ppb/7) Obtained from Six TOCSY Spectra Every 57 over a Temperature Range of 25 to 457
Residue HN a b Others ACSTD
A1 — 4.09 1.50 — —
L2 8.55 4.36 1.61 gCH 06.9 1.61
dCH3  0.88, 0.92
D3 8.44 4.62 2.74, 2.80 — 08.2
K4 8.28 4.26 1.77, 1.85 gCH2 08.9 1.43
dCH2  1.68
eCH2  2.99
eNH3  7.51
L5 8.21 4.31 1.68 gCH 07.5 1.61
dCH3  0.88, 0.93
E6 8.25 4.33 2.00, 2.11 gCH2 05.0 2.43
E7 8.31 4.35 2.01, 2.13 gCH2 06.5 2.44
S8 8.32 4.42 3.87, 3.91 — 06.2
N9 8.41 4.74 2.80, 2.88 NH2 05.3 6.88, 7.60
S10 8.24 4.40 3.87, 3.92 — 05.3
K11 8.26 4.30 1.88, 1.78 gCH2 02.9 1.45
dCH2  1.68
eCH2  2.99
eNH3  7.51
L12 8.00 4.33 1.63 gCH 03.3 1.60
dCH3  0.86, 0.92
D13 8.22 4.63 2.73, 2.82 — 03.3
K14 8.15 4.32 1.85, 1.75 gCH2 05.9 1.40, 1.44
dCH2  1.68
eCH2  3.00
eNH3  7.51
V15 8.03 4.09 2.08 gCH3 03.3 0.93
N16 8.49 4.73 2.72, 2.82 NH2 06.8 6.88, 7.60
V17 7.97 4.10 2.08 gCH3 010.0 0.92
K18 8.33 4.36 1.75, 1.84 gCH2 07.2 1.40, 1.44
dCH2  1.67
eCH2  2.99
eNH3  7.51
L19 8.36 4.44 1.66 gCH 09.6 1.66
dCH3  0.87, 0.95
T20 7.75 4.24 4.29 gCH3 03.6 1.16
047) or a 310-helix (f  049, C  026) (Creighton, 1984; resulting in a discontinuous hydrophobic strip which
might impart less structural stability (Segrest et al., 1990).Wu¨thrich et al., 1984), but represent a helix that may be
between an a-helix and a 310-helix. The structure obtained It has been shown that a peptide with no hydrophobic
face can take on a helical structure if it contains lysinefor WTF20 appears to represent a leucine zipper since
L5, L12, and L19 are aligned along on one face of the and glutamic acid in certain positions (Ptitsyn, 1992;
Scholtz and Baldwin, 1992; Zhu et al., 1993). The sidehelix (Gonzalez et al., 1996; Harbury et al., 1993; Junius
et al., 1996) (Fig. 9A). In contrast, the leucines would shift chain /NH3 of lysine can form a salt bridge with the side
chain COO0 of glutamic acid in the i/ 3 or i/ 4 position.in position in opposite directions around the axis of a 310-
helix (Fig. 9B) or an a-helix (Fig. 9C). The single family of conformations determined for WTF20
suggested a stable helix even though this peptide has aPeptides that take on a stable helical conformation
in aqueous solution often contain a hydrophobic strip discontinuous hydrophobic strip. The additional struc-
tural stability of the peptide likely results from both side(Ptitsyn, 1992; Scholtz and Baldwin, 1992; Young et al.,
1997). For example, a peptide that has an L, I, F, V, or M chain salt bridges and hydrogen bonds. A representative
structure of WTF20 with side chain salt bridge and hydro-residue in either the ‘‘d-a’’, ‘‘a-e’’, or ‘‘d-a-e’’ positions of
a helix (Fig. 1D) form a continuous hydrophobic strip gen bonds labeled is shown in Fig. 8C. K4 forms a salt
bridge with E7 (i / 3), and E7 forms a salt bridge withproviding most of the structural stability. However, a leu-
cine or isoleucine zipper peptide often contains only leu- K11 (i / 4). The conformation calculated for WTF20 also
contains two strong side chain hydrogen bonds from thecine or isoleucine in the ‘‘a’’ or ‘‘d’’ position of a helix,
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FIG. 7. Structural ROEs of WTF20. ROEs obtained from the ROESY spectrum of WTF20 in aqueous solution. The bars show the position and
strength of each ROE. The pattern expected for an ideal a-helix and a 310-helix are shown to the right.
O of S10 to the /NH3 of K14 (2.35 A˚) and from the COO
0 However, a physiologically significant interaction of pep-
tides like WTF20 with membranes is less likely sinceof D13 to the NH2 of N16 (2.70 A˚) and a medium hydrogen
bond from the /NH3 of K18 to the backbone O of K14 this sort of interaction is difficult to reconcile with their
(3.00 A˚). reported virus specificity. Furthermore, the finding that
NDV fusion is inhibited only when WTF20 is added prior
Peptide inhibition of fusion to cleavage is inconsistent with a membrane interaction.
In the Sendai virus (SV) system, evidence was presentedHow WTF20 inhibits fusion or how any of the other
that, while the SV peptide had an affinity for membranes,inhibitory peptides previously studied inhibit paramyxovi-
an interaction with viral proteins was likely (Rapaport etrus fusion is unknown. Furthermore, neither the structural
al., 1995).properties of these peptides important to inhibition nor
These HR2-derived peptides could interact with eithertheir targets are clear. In postulating mechanisms for the
the F or the HN protein. The finding that inhibition ofinhibitory activity of these peptides, several results from
NDV fusion can occur prior to F0 protein cleavage maythis study and others may be relevant to this problem.
suggest two possibilities. First, if the peptide interactsFirst, as shown in this work, the WTF20 peptide forms a
with HN, then any HN–peptide interaction is not inhibi-helix in aqueous solution with leucine residues aligned
tory after cleavage of the F protein and the initial onseton one face (Fig. 9A). This property has not been clearly
of fusion, events that both likely occur during incubationdemonstrated with other paramyxovirus peptides, al-
with trypsin. Alternatively, this result may suggest a pep-though there have been suggestions of such a structure
tide–F protein interaction. It has been shown that the F(Lambert et al., 1996). Second, in other studies it has
protein undergoes a conformational change upon cleav-been found that inhibition of fusion is virus specific (Lam-
age (Hsu et al., 1981) which could alter potential peptide–bert et al., 1996; Yao and Compans, 1996), although in
F protein interactions. Further, the leucine zipper motifsone study where inhibition was quantitated the specificity
in both the peptide and the F protein make such a pro-was not absolute (Lambert et al., 1996). For example, a
posal attractive. However, can structural information inpeptide with a sequence from the PIV3 F (HR2 region)
this study predict an interaction between the peptide andprotein did show some activity against measles virus and
the F protein that can account for the virus specificitiesrespiratory syncytial virus fusion (Lambert et al., 1996).
reported in other systems? Analysis of the structure de-Third, as shown here, the NDV peptide exerted its effect
termined for WTF20 as well as a comparison of the se-prior to the cleavage of the fusion protein, but not after
quences of the HR2 region in other paramyxoviruses sug-cleavage and initiation of fusion. This point has not been
gest that the amino acids in the ‘‘a’’ position as well asaddressed in other systems.
the ‘‘e’’ and ‘‘g’’ positions could account for specificity.Potentially WTF20 may inhibit fusion by interacting with
A representative surface structure of WTF20 obtainedmembranes, with the F protein, or with the HN protein.
from molecular modeling is shown in Fig. 8B (L2, L5, L12,Helical peptides have the potential to associate with lipid
bilayers changing their properties (Brasseur et al., 1997). and L19 are shown in green). L5, L12, and L19 form large
AID VY 8834 / 6a53$$$$24 10-28-97 14:41:11 vira AP: VY
301PEPTIDE INHIBITOR OF VIRUS FUSION
FI
G
.
8.
S
tr
uc
tu
re
s
of
W
TF
20
ob
ta
in
ed
fr
om
m
ol
ec
ul
ar
m
od
el
in
g.
(A
)
Tw
en
ty
ra
nd
om
ly
se
le
ct
ed
st
ru
ct
ur
es
of
W
TF
20
fr
om
si
m
ul
at
ed
an
ne
al
in
g
ca
lc
ul
at
io
ns
us
in
g
in
te
rp
ro
to
n
di
st
an
ce
an
d
in
tr
am
ol
ec
ul
ar
hy
dr
og
en
bo
nd
da
ta
su
pe
rim
po
se
d
ba
ck
bo
ne
on
ly
.A
rib
bo
n
is
sh
ow
n
th
ro
ug
h
th
e
ba
ck
bo
ne
at
om
s
to
hi
gh
lig
ht
th
e
he
lic
al
st
ru
ct
ur
e.
(B
)
A
re
pr
es
en
ta
tiv
e
st
ru
ct
ur
e
of
W
TF
20
sh
ow
in
g
si
de
ch
ai
n
sa
lt
br
id
ge
s
an
d
hy
dr
og
en
bo
nd
s.
(C
)
S
ol
id
su
rf
ac
e
of
a
re
pr
es
en
ta
tiv
e
st
ru
ct
ur
e
of
W
TF
20
sh
ow
in
g
th
e
de
ep
ho
le
s
re
su
lti
ng
fr
om
th
e
L5
,L
12
,a
nd
L1
9
zi
pp
er
m
ot
if.
L2
,L
5,
L1
2,
an
d
L1
9
ar
e
sh
ow
n
in
gr
ee
n,
ac
id
ic
re
si
du
es
ar
e
in
re
d,
an
d
ba
si
c
re
si
du
es
ar
e
in
bl
ue
.(
D
)
S
ol
id
su
rf
ac
e
re
pr
es
en
ta
tio
n
of
th
e
kn
ob
-in
-h
ol
e
pa
ck
in
g
be
tw
ee
n
W
TF
20
(b
ot
to
m
)
an
d
a
hy
po
th
et
ic
al
se
qu
en
ce
w
ith
a
zi
pp
er
m
ot
if
(to
p)
.L
2,
L5
,L
12
,a
nd
L1
9
ar
e
sh
ow
n
in
gr
ee
n
fo
r
W
TF
20
,a
s
ar
e
La
,L
b,
an
d
Lc
of
th
e
se
qu
en
ce
.
AID VY 8834 / 6a53$$8834 10-28-97 14:41:11 vira AP: VY
302 YOUNG ET AL.
TABLE 2 residue, resulting in unfavorable contacts of La of the
sequence with both L2 and L5 of WTF20. However, iso-Backbone Dihedral Angles for WFT20 Averaged over the 100
leucine can be positioned in this depression. Thus theStructures from Molecular Modeling
shape of the depressions between residues in the ‘‘a’’
A1 f  — K11 f  069.3 { 2.6 position as well as the distribution of isoleucines and
C  051.1 { 28.0 C  036.4 { 9.4 leucines in the different ‘‘a’’ positions could account, at
L2 f  063.4 { 9.6 L12 f  062.3 { 2.3
least in part, for specificity through a peptide–F zipperC  030.4 { 3.0 C  026.9 { 9.6
interaction. A comparison of the ‘‘a’’ positions in eightD3 f  081.3 { 1.1 D13 f  073.8 { 6.4
C  026.9 { 2.3 C  032.1 { 5.9 paramyxoviruses (Table 3) shows significant differences
K4 f  067.6 { 5.2 K14 f  091.1 { 7.0 in the distribution of isoleucines and leucines (under-
C  038.5 { 4.8 C  025.9 { 6.9 lined) in the ‘‘a’’ positions. In fact, the fifth ‘‘a’’ position
L5 f  063.3 { 1.8 V15 f  076.6 { 4.0
shows the most variation among these paramyxoviruses.C  030.5 { 2.0 C  040.1 { 4.5
However, this distribution in the ‘‘a’’ position may not beE6 f  063.1 { 6.1 N16 f  066.5 { 4.3
C  028.2 { 5.9 C  024.7 { 9.9 sufficient to account for specificity since some viruses
E7 f  070.1 { 4.9 V17 f  080.1 { 7.0 (see RV and SV) have identical patterns.
C  042.2 { 2.5 C  025.4 { 9.0
Studies of transcription factors which interact via leu-S8 f  053.6 { 1.0 K18 f  056.8 { 6.1
cine zippers have shown that charged amino acids inC  029.5 { 1.4 C  025.7 { 8.2
N9 f  068.3 { 1.1 L19 f  064.1 { 8.7 the ‘‘e’’ and ‘‘g’’ positions in a helix are important determi-
C  029.5 { 8.6 C  046.4 { 7.9 nants of oligomerization specificity (Lupas, 1996; O’Shea
S10 f  064.6 { 9.2 T20 f  032.9 { 81.9 et al., 1992). Some homo- and heterodimers form favor-
C  028.6 { 10.9 C  —
able interactions between either a lysine or a glutamic
acid in the ‘‘e’’ or ‘‘g’’ position of one helix with a glutamic
acid or a lysine in the ‘‘e’’ or ‘‘g’’ position (termed e* andextensions from the backbone of the helix and define
g* ) of another helix. A comparison of the ‘‘e’’ and ‘‘g’’large holes between L5 and L12 and L12 and L19. In
position in eight paramyxoviruses (Table 3, chargesorder to determine if another sequence with a leucine
underlined) shows considerable variability at these posi-zipper motif could interact with this peptide, a 20-aa se-
tions. Therefore, paramyxovirus fusion specificity may re-quence with a leucine in positions 5, 12, and 19 (La, Lb,
sult from a combination of the occurrence and distribu-and Lc) and alanine in all other positions was con-
tion of isoleucines or leucines in the ‘‘a’’ position andstructed based on the dihedral angles obtained from mo-
charged amino acids in the ‘‘e’’ and ‘‘g’’ positions.lecular modeling of WTF20 (Table 2). As can be seen in
In conclusion, we have shown that peptide WTF20 withFig. 8D, this sequence can form a zipper with WTF20 by
a sequence from the HR2 zipper motif of the NDV Finterdigitating the leucine residues of both peptides. The
protein inhibited virus fusion. This peptide has also beendepressions formed between L5 and L12 and L12 and
shown to exert its effect prior to the cleavage of theL19 in WTF20 are large enough to accommodate the Lb
fusion protein. NMR and molecular modeling of WTF20and Lc residues of the other sequence. However, the
hole at the N-terminal side of L5 is restricted by the L2 revealed a helical conformation in aqueous solution with
FIG. 9. Representation of WTF20 in different helical conformations. (A) Helical structure calculated for WTF20 showing L5, L12, and L19 aligned
on one face. (B) WTF20 in an a-helix conformation. (C) WTF20 in a 310-helix conformation.
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TABLE 3
Comparison of the Sequence in the Zipper Region (HR2) of the F Protein of Different Paramyxoviruses Showing Different Patterns
of Isoleucines and Leucines in the ‘‘a’’ Position and Charges in the ‘‘e’’ and ‘‘g’’ Positions
Virus Positions of the helix
‘‘a’’ positions abcdefg abcdefg abcdefg abcdefg abcdefg a
NDV L I L L L I
SV L L L L Y I
RSV I I I L K I
PI3 L L I L H I
MuV L L I L S V
SV5 L L L L T I
RV L L L L S I
MV L L L L S I
‘‘e’’ positions abcdefg abcdefg abcdefg abcdefg abcdefg
NDV N L N N S
SV T K R G E
RSV N L D N N
PI3 K K N N N
MuV N V N S A
SV5 N L D T V
RV V K D K T
MV I K D K I
‘‘g’’ positions abcdefg abcdefg abcdefg abcdefg abcdefg
NDV S K K K L
SV F E I W V
RSV K F L G M
PI3 D W K G M
MuV S Y Q N I
SV5 S H Y A S
RV K L I V Y
MV K L I L Y
Note. See Fig. 1D. Major differences in the ‘‘a’’ positions and charges in the ‘‘e’’ and ‘‘g’’ positions are underlined. NDV, Newcastle disease virus;
SV, Sendai virus; RSV, respiratory syncytial virus; PI3, parainfluenza virus; MuV, mumps virus; SV5, simian virus 5; RV, rhinderpest virus; and MV,
measles virus.
(1997). Peptides in membranes: Tipping the balance of membranethe leucines in the ‘‘a’’ positions aligned on one face.
stability. Trends Biochem. Sci. 22, 167–171.Considerations of this structure have suggested that
Buckland, R., Malvoisin, E., Beauverger, P., and Wild, F. (1992). A leucine
specificity of the peptide may result from a combination zipper structure present in the measles virus fusion protein is not
of the occurrence and distribution of isoleucines or leu- required for its tetramerization but is essential for fusion. J. Gen.
Virol. 73, 1703–1707.cines in the ‘‘a’’ position and charged amino acids in the
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